
Flunarizine (10mg) + Propranolol (40mg)
Active composition
+1 more active ingredient
Flunarizine acts as a calcium channel blocker, preventing vasodilation and reducing the frequency of migraine attacks.
Propranolol blocks beta-1 and beta-2 adrenergic receptors, resulting in decreased heart rate, myocardial contractility, and overall cardiac output.
Medical applications
Migablok 40mg/10mg Tablet is a combination medication containing Propranolol (40mg) and Flunarizine (10mg) indicated for the prophylactic treatment of migraines and prevention of episodic vasospasm. Propranolol, a beta blocker, helps to reduce the frequency and severity of migraines by decreasing blood pressure and vasospasm. Flunarizine, a calcium channel blocker, also contributes to the prevention of vasospasm and the reduction of migraine symptoms. This tablet is suitable for adult patients experiencing frequent or severe migraines, as well as those with a history of vasospasm. The recommended dose is one tablet taken orally twice daily. Migablok 40mg/10mg Tablet should be used with caution in patients with a history of depression, bronchial asthma, or chronic kidney disease. Patients should be monitored for any signs of decreased blood pressure or increased heart rate. The most common side effects include dizziness, lightheadedness, and fatigue. Patients should consult their doctor or pharmacist if they experience any adverse reactions.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Migablok 40mg/10mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Information regarding the use of Migablok 40mg/10mg Tablet during breastfeeding is not available. Please consult your doctor.
Medical Advice
Migablok 40mg/10mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Migablok 40mg/10mg Tablet may be needed. Please consult your doctor.
Exercise Caution
It is not known whether Migablok 40mg/10mg Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
Migablok 40mg/10mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Migablok 40mg/10mg Tablet may be needed. Please consult your doctor. Regular monitoring of blood pressure is advisable for dose adjustment.
Regular Checkup
0 reviews for Migablok 40mg/10mg Tablet

Propranolol (40mg) + Flunarizine (10mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Flunarizine acts as a calcium channel blocker, preventing vasodilation and reducing the frequency of migraine attacks.
Propranolol blocks beta-1 and beta-2 adrenergic receptors, resulting in decreased heart rate, myocardial contractility, and overall cardiac output.
Medical applications
Migablok 40mg/10mg Tablet is a combination medication containing Propranolol (40mg) and Flunarizine (10mg) indicated for the prophylactic treatment of migraines and prevention of episodic vasospasm. Propranolol, a beta blocker, helps to reduce the frequency and severity of migraines by decreasing blood pressure and vasospasm. Flunarizine, a calcium channel blocker, also contributes to the prevention of vasospasm and the reduction of migraine symptoms. This tablet is suitable for adult patients experiencing frequent or severe migraines, as well as those with a history of vasospasm. The recommended dose is one tablet taken orally twice daily. Migablok 40mg/10mg Tablet should be used with caution in patients with a history of depression, bronchial asthma, or chronic kidney disease. Patients should be monitored for any signs of decreased blood pressure or increased heart rate. The most common side effects include dizziness, lightheadedness, and fatigue. Patients should consult their doctor or pharmacist if they experience any adverse reactions.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Migablok 40mg/10mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Information regarding the use of Migablok 40mg/10mg Tablet during breastfeeding is not available. Please consult your doctor.
Medical Advice
Migablok 40mg/10mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Migablok 40mg/10mg Tablet may be needed. Please consult your doctor.
Exercise Caution
It is not known whether Migablok 40mg/10mg Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
Migablok 40mg/10mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Migablok 40mg/10mg Tablet may be needed. Please consult your doctor. Regular monitoring of blood pressure is advisable for dose adjustment.
Regular Checkup
0 reviews for Migablok 40mg/10mg Tablet















